Watch CBS News
Johnson and Johnson has resumed production of its coronavirus vaccine after the CDC and FDA lifted a pause to review safety issues. The vaccines will now come with a warning about the potential risk of rare, but dangerous blood clots. Danya Bacchus reports.
A CDC panel recommended Friday to end the pause on the Johnson & Johnson vaccine. But the shot will come with a warning about the potential risk of rare, but dangerous, blood clots. Nikki Battiste has the details.
Federal health officials have given the green light to resume use of Johnson and Johnson's coronavirus vaccine. A CDC panel recommended Friday to resume using the vaccine, more than a week after it was put on pause over reports of blood clots. As Nikki Battiste reports, the vaccine will now come with a warning for some women. Dr. Payal Patel, an infectious diseases physician at the Universy of Michigan's Medical School, joined CBSN's Lana Zak to discuss the decision.
Dr. Jon LaPook explains why the new warning with the Johnson and Johnson vaccine is primarily for women under the age of 50.
A decision is expected Friday, more than a week after the vaccine's distribution was paused following reports of rare but dangerous blood clots in eight people under the age of 50.
The CDC and FDA are leaning toward resuming the Johnson & Johnson vaccine after it was halted following reports of blood clots, sources told CBS News. Janet Shamlian has more.
A slowing pace of coronavirus vaccinations in the U.S. is fueling concerns that vaccine supply will soon exceed demand. As Janet Shamlian reports, efforts are lagging in the South and Midwest. Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University's Bloomberg School of Public Health, joined CBSN's Lana Zak to discuss the latest.
Security footage showed peeling paint and workers carrying open bags of medical waste.
The Food and Drug Administration has ordered one manufacturing plant to stop its production of Johnson & Johnson vaccine after contamination was found. Meanwhile, Dr. Anthony Fauci says he expects access to Johnson and Johnson doses to resume later this week. CBS News' Laura Podesta joins CBSN AM with an update.
Dr. Scott Gottlieb, the former FDA commissioner, says the pause on the single-dose vaccine could be lifted with additional restrictions on who should receive it, and warnings about potential side effects.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired April 18, 2021, on "Face the Nation."
An emergency meeting of a Centers for Disease Control and Prevention advisory committee was held to discuss the extremely rare blood clots possibly associated with the Johnson and Johnson COVID-19 vaccine. The meeting ended without a decision on when the shots can be given again. CBS News' Laura Podesta joined "CBSN AM" with the latest.
The Centers for Disease Control and Prevention and the Food and Drug Administration say to stop administering Johnson & Johnson vaccines amid reports of six women who suffered from a rare blood clot days after receiving the company's vaccine. Dr. Dyan Hes, the founder of Gramercy Pediatrics in New York City, joins CBSN to discuss the latest on COVID-19.
The Centers for Disease Control and Prevention are preparing to hold an emergency meeting Tuesday to discuss the pause on the Johnson and Johnson vaccine, due to six cases of rare but severe blood clots. All 50 states have temporarily stopped use of these shots. CBS News' Laura Podesta joins CBSN AM with the latest.
More than 7.2 million Americans have received the Johnson & Johnson COVID-19 vaccine and at least six of them developed serious blood clots. The CDC and FDA say the condition appears to be "extremely rare," but asked for the vaccine pause "out of an abundance of caution." Nancy Cordes reports.
The cases being investigated occurred in women between the ages of 18 and 48.
All 50 states are halting use of Johnson and Johnson's coronavirus vaccine after at least six women developed blood clots. As CBS News' Jericka Duncan reports, the FDA and the CDC recommended a temporary pause to investigate these cases out of an "abundance of caution." Dr. Taison Bell, a critical care and infectious disease physician and the medical ICU director at the University of Virginia, joins CBSN's Elaine Quijano to discuss the latest.
The Food and Drug Administration plans to propose limits on arsenic, lead and mercury in baby food, with the agency taking action two months after a congressional report found products from several of the country's largest manufacturers "tainted" with toxic heavy metals.
Agency's plan comes two months after congressional report found toxic heavy metals in products for infants.
The Biden administration says that pausing the distribution of Johnson & Johnson's coronavirus vaccine should not hamper the nation's ongoing vaccine efforts. As CBS News' Skyler Henry reports, the announcement comes as the U.S. calls to pause the distribution of the Johnson & Johnson vaccine after receiving reports that at least six women had suffered a rare blood-clotting disorder after getting their shot. Dr. Julie Morita, a former member of the Biden administration transition advisory board and the executive vice president of the Rober Wood Johnson Foundation, joins CBSN's Tanya Rivero to discuss the impact the pause could have on the nation's vaccine efforts.
The CDC and FDA have issued a joint statement recommending a pause in the use of the Johnson & Johnson COVID-19 vaccine in the United States. The agencies say they are reviewing six reported cases of a rare type of blood clot in people who have received the vaccine. Nearly 7 million doses have already been administered in the country.
The FDA announced Monday evening that it would temporarily pause a medication abortion restriction that requires the pills to be dispensed in person.
The CDC and FDA have issued a joint statement recommending a pause in the use of the Johnson and Johnson COVID-19 vaccine in the United States after six reports of blood clots in recipients. Nearly 7 million doses have been administered. Dr. David Agus joins "CBS This Morning" to discuss the developing facts Americans need to know.
As of Monday over 6.8 million doses of the single-dose vaccine had been administered across the country.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired April 11, 2021, on "Face the Nation."
